Care in the time of coronavirus: Ethical considerations in head and neck oncology.
Where this comes from
- Record sourced from PubMed, PMID 32437032.
- Also identified by DOI 10.1002/hed.26272 and PMC identifier 7280596.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
As COVID-19 continues to challenge the practice of head and neck oncology, clinicians are forced to make new decisions in the setting of the pandemic that impact the safety of their patients, their institutions, and themselves. The difficulty inherent in these decisions is compounded by potentially serious ramifications to the welfare of patients and health-care staff, amid a scarcity of data on which to base informed choices. This paper explores the risks of COVID-19 incurred while striving to uphold the standard of care in head and neck oncology. The ethical problems are assessed from the perspective of the patient with cancer, health-care provider, and other patients within the health-care system. While no single management algorithm for head and neck cancer can be universally implemented, a detailed examination of these issues is necessary to formulate ethically sound treatment strategies.
Medical subject headings
- Betacoronavirus
- Coronavirus Infections
- Head and Neck Neoplasms
- Medical Oncology
- Pandemics
- Pneumonia, Viral